Search

Your search keyword '"Leliveld A"' showing total 1,165 results
Start Over Author "Leliveld A"
1,165 results on '"Leliveld A"'

2. Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

Author

Thomas van Doeveren, Sebastiaan Remmers, Vera Atema, Roderick C.N. van den Bergh, Egbert R. Boevé, Erik B. Cornel, Antoine G. van der Heijden, Kees Hendricksen, Evelyne C.C. Cauberg, Rens A.L. Jacobs, Bin K. Kroon, Annemarie M. Leliveld, Richard P. Meijer, Bob Merks, Jorg R. Oddens, Luc Roelofs, Diederik M. Somford, Peter de Vries, Bart Wijsman, Willemijn A.K.M. Windt, Peter J. Zwaan, Pim J. van Leeuwen, Joost L. Boormans, and Katja K.H. Aben

Subjects
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30, Health-related quality of life, Radical surgery, Short term, Upper urinary tract, Urothelial carcinoma, Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Background and objective: The possible negative impact of radical surgery on patients’ health-related quality of life (HRQoL) plays an important role in preoperative counseling. Here, we analyzed the HRQoL of patients treated for upper urinary tract urothelial carcinoma (UTUC) in the context of a single-arm phase 2 multicenter study, in which the safety and efficacy of a single preoperative intravesical instillation with mitomycin C were investigated. Our objective was to investigate early changes in HRQoL in patients undergoing radical surgery for UTUC and identify factors associated with these outcomes. Methods: Patients with pTanyN0-1M0 UTUC were prospectively included. HRQoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire at baseline, and at 1 and 3 mo after surgery. A linear mixed model was used to evaluate the changes in HRQoL over time and identify the variables associated with these outcomes. The clinical effect size was used to assess the clinical impact and level of perceptibility of HRQoL changes for clinicians and/or patients based on given thresholds. Key findings and limitations: Between 2017 and 2020, 186 patients were included. At baseline, 1 mo after surgery, and 3 mo after surgery, response rates were 91%, 84%, and 78%, respectively. One month after surgery, a statistically significant and clinically relevant deterioration was observed in physical, role, and social functioning, and for the included symptom scales: constipation, fatigue, and pain. An improvement in emotional functioning was observed. At 3 mo, HRQoL returned to baseline levels, except emotional functioning, which improved at 1 mo and persisted to be better than that before surgery. Age >70 yr was associated with worse physical functioning, but better social and emotional functioning. Male patients reported better emotional functioning than females. Postoperative complications were negatively associated with social functioning. Conclusions and clinical implications: UTUC patients treated with radical surgery experienced a significant, albeit temporary, decline in HRQoL. Three months following surgery, HRQoL outcomes returned to baseline levels. This information can be used to counsel UTUC patients before undergoing radical surgery and contextualize recovery after surgery. Patient summary: We investigated the changes in quality of life as reported by patients who underwent surgery for upper tract urothelial carcinoma (UTUC). We found that patients experienced a decline in quality of life 1 mo after surgery, but this was temporary, with full recovery of quality of life 3 mo after surgery. These findings can help doctors and other medical staff in counseling UTUC patients before undergoing radical surgery.

Published
2024
Full Text
View/download PDF

4. Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

Author

van Doeveren, Thomas, Remmers, Sebastiaan, Atema, Vera, van den Bergh, Roderick C.N., Boevé, Egbert R., Cornel, Erik B., van der Heijden, Antoine G., Hendricksen, Kees, Cauberg, Evelyne C.C., Jacobs, Rens A.L., Kroon, Bin K., Leliveld, Annemarie M., Meijer, Richard P., Merks, Bob, Oddens, Jorg R., Roelofs, Luc, Somford, Diederik M., de Vries, Peter, Wijsman, Bart, Windt, Willemijn A.K.M., Zwaan, Peter J., van Leeuwen, Pim J., Boormans, Joost L., and Aben, Katja K.H.

Published
2024
Full Text
View/download PDF

10. Pulmonary function 3–6 months after acute COVID-19: A systematic review and multicentre cohort study

Author

Merel E.B. Cornelissen, Asabi Leliveld, Nadia Baalbaki, Debbie Gach, Ivo van der Lee, Esther J. Nossent, Lizan D. Bloemsma, and Anke H. Maitland-van der Zee

Subjects
Post COVID-19, Pulmonary function, Transfer factor for carbon monoxide, Long COVID, Science (General), Q1-390, Social sciences (General), H1-99
Abstract

Aims: To describe pulmonary function 3–6 months following acute COVID-19, to evaluate potential predictors of decreased pulmonary function and to review literature for the effect of COVID-19 on pulmonary function. Materials and methods: A systematic review and cohort study were conducted. Within the P4O2 COVID-19 cohort, 95 patients aged 40–65 years were recruited from outpatient post-COVID-19 clinics in five Dutch hospitals between May 2021–September 2022. At 3–6 months post COVID-19, medical records data and biological samples were collected and questionnaires were administered. In addition, pulmonary function tests (PFTs), including spirometry and transfer factor, were performed. To identify factors associated with PFTs, linear regression analyses were conducted, adjusted for covariates. Results: In PFTs (n = 90), mean ± SD % of predicted was 89.7 ± 18.2 for forced vital capacity (FVC) and 79.8 ± 20.0 for transfer factor for carbon monoxide (DLCO). FVC was

Published
2024
Full Text
View/download PDF

11. Author Correction: Classification of pig calls produced from birth to slaughter according to their emotional valence and context of production

Author

Briefer, Elodie F., Sypherd, Ciara C.‑R., Linhart, Pavel, Leliveld, Lisette M. C., Padilla de la Torre, Monica, Read, Eva R., Guérin, Carole, Deiss, Véronique, Monestier, Chloé, Rasmussen, Jeppe H., Špinka, Marek, Düpjan, Sandra, Boissy, Alain, Janczak, Andrew M., Hillmann, Edna, and Tallet, Céline

Published
2023
Full Text
View/download PDF

13. What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals

Author

Babette Verkouteren, Dan Piña-Fuentes, Martijn Beudel, Thomas Ludden, Rik H G Olde Engberink, Tom Dormans, Martijn D de Kruif, Suat Simsek, Joop P van den Bergh, Hazra Moeniralam, Renee Douma, Kees Brinkman, Wouter Hinsenveld, Lucas Ramos, Anne Pirson, Deborah Hubers, Shi Hu, Rajat Thomas, Michiel Schinkel, Caroline E Wyers, Daisy Rusch, Lianne de Haan, Niels C Gritters van den Oever, Nienke Paternotte, Robert-Jan Goldhoorn, Brent Appelman, Esther Lems, Marije ten Wolde, Esther K Haspels-Hogervorst, Neyma Bokhizzou, Niels Gritters van den Oever, Joop van den Bergh, Martijn de Kruif, Helen Leavis, Derk Arts, Nick Nurmohamed, Rens Reeskamp, Willem Herter, Bas Vonk, Ricardo Lopes, Deborah Huberts, Marije Wolfers, Sander de Kuij, Sophie Noordzij, Sibbeliene van den Bosch, Benthe Verhoef, Michele Methorst, Shahan Darwesh, Tijn van Egmond, Gulsum Nasim, Hamza Ali, Lars de Boer, Myrthe Nagel, Maud Koenis, Agnetha Bijlsma, Britt Balvers, Isabella Ghauharali, Jelle de Jongh, Maira Emanuel, Nisrine Aynaou, Rosemarie de Ridder, Insaff Darraz, Oumaima Darraz, Alanar Cinar, Jesse Roosen, Larissa Heideman, Asabi Leliveld, Dana Ruijter, Neeltje Rosenberg, Djoeke Woutman, Tom Vermeulen, Sam de Joode, Willem Berger, Ozgu Varan, Soesja Pinto, Sientje Sluis, Bibi Kuiper, Tim van der Putten, Dominique Bosje, Mahunda Sinyangwe, Roos van Rhijn, Koen Kruif, Miriam den Heijer, Koen de Kruijf, Sam Hofhuis, Gwendolyn Telting, Susan van der Lei, Pien van Paassen, Emil ter Veer, Krijna Opschoor, Camille Breukhoven, Florine Jiwa, Peter de Gooyer, Jan Vrijdag, Stans van Gelder, Anne Pannekoek, Laura Dommershuijzen, Estelle Adang, Maud van Maren, Isabel Koop, Bart Sanders, Joukje Wanten, Dax Trommelen, Fleur Smeets, Kyra Heuvelings, Maud Cox, Milou Rademaekers, Vivian Hendrikx, Ilona van Rooij, Wendy Heuts, Laura Oudeman, Evelien Brans, Karin Slot, Kirsten Boerma-Argelo, Wilma Kok, Lieke Harmsen, Ingrid Boerema, Anne Raafs, Anne Smaal, Bibiane Pop, Carmen Waterink, Casper Vrij, Daphne van der Willik, Frederic Reitsma, Imogene Pieters, Jade Logger, Laura Sijben, Maikel Peeters, Mariël Teunissen, Marije Blok-Hoos, Marjolein Ketels, Michiel Henkens, Mireille Spanjers, Monique Jacob-Dols, Patrick de Hoogt, Rik Houben, Roos van Gorp, and Josien Jansen

Subjects
Medicine
Abstract

Objectives To evaluate the relationship among dysnatraemia at hospital presentation and duration of admission, risk of intensive care unit (ICU) admission and all-cause mortality and to assess the underlying pathophysiological mechanism of hyponatraemia in patients with COVID-19. Our hypothesis is that both hyponatraemia and hypernatraemia at presentation are associated with adverse outcomes.Design Observational study.Setting Secondary care; 11 Dutch hospitals (2 university and 9 general hospitals).Participants An analysis was performed within the retrospective multicentre cohort study COVIDPredict. 7811 patients were included (60% men, 40% women) between 24 February 2020 and 9 August 2022. Patients who were ≥18 years with PCR-confirmed COVID-19 or CT with COVID-19 reporting and data system score≥4 and alternative diagnosis were included. Patients were excluded when serum sodium levels at presentation were not registered in the database or when they had been transferred from another participating hospital.Outcome measures We studied demographics, medical history, symptoms and outcomes. Patients were stratified according to serum sodium concentration and urinary sodium excretion.Results Hyponatraemia was present in 2677 (34.2%) patients and hypernatraemia in 126 (1.6%) patients. Patients with hyponatraemia presented more frequently with diarrhoea, lower blood pressure and tachycardia. Hyponatraemia was, despite a higher risk for ICU admission (OR 1.27 (1.11–1.46; p

Published
2023
Full Text
View/download PDF

15. VEGF, EGFR and PSMA as possible imaging targets of lymph node metastases of urothelial carcinoma of the bladder

Author

Christa Anne Maria van der Fels, Annemarie Leliveld, Henk Buikema, Marius Christianus van den Heuvel, and Igle Jan de Jong

Subjects
Bladder cancer, Urothelial carcinoma, Lymph nodes, Targeted imaging, Antigens, Diseases of the genitourinary system. Urology, RC870-923
Abstract

Abstract Background In this study we investigated the expression of vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR) and prostate-specific membrane antigen (PSMA) to analyze their potency as targets for the detection of lymph node (LN) metastases of urothelial carcinoma of the bladder. Methods Antigen expression was determined in 40 samples with urothelial carcinoma and compared to 17 matched samples without metastases by immunohistochemistry. The total immunostaining score (TIS 0–12) was determined as the product of a proportion score (PS 0–4) and intensity score (IS 0–3). Results VEGF expression was high in primary tumor and LN metastases (median TIS 8 in both) and VEGF expression was also seen in LNs without metastases (median TIS 6). EGFR expression was low in primary tumor and LN metastases (median TIS 3 and 2 respectively) and absent in LNs without metastases. PSMA expression was low in samples with urothelial carcinoma (median TIS 2). Conclusion VEGF shows moderate to high expression levels in both primary tumors and LN metastases and could be a candidate as a target agent for imaging modalities of urothelial carcinoma. EGFR and PSMA do show low staining levels in tumor tissue with urothelial carcinoma and do not seem suitable as target agents. Trial registration: The Medical Ethics Review Board of the University Medical Center Groningen approved this study on 14 December 2017 (METc UMCG 2017/639). Trial registration number (UMCG Research Register): 201700868.

Published
2022
Full Text
View/download PDF

17. Situational factors shape moral judgements in the trolley dilemma in Eastern, Southern and Western countries in a culturally diverse sample

Author

Bago, Bence, Kovacs, Marton, Protzko, John, Nagy, Tamas, Kekecs, Zoltan, Palfi, Bence, Adamkovic, Matus, Adamus, Sylwia, Albalooshi, Sumaya, Albayrak-Aydemir, Nihan, Alfian, Ilham N., Alper, Sinan, Alvarez-Solas, Sara, Alves, Sara G., Amaya, Santiago, Andresen, Pia K., Anjum, Gulnaz, Ansari, Daniel, Arriaga, Patrícia, Aruta, John Jamir Benzon R., Arvanitis, Alexios, Babincak, Peter, Barzykowski, Krystian, Bashour, Bana, Baskin, Ernest, Batalha, Luisa, Batres, Carlota, Bavolar, Jozef, Bayrak, Fatih, Becker, Benjamin, Becker, Maja, Belaus, Anabel, Białek, Michał, Bilancini, Ennio, Boller, Daniel, Boncinelli, Leonardo, Boudesseul, Jordane, Brown, Benjamin T., Buchanan, Erin M., Butt, Muhammad M., Calvillo, Dustin P., Carnes, Nate C., Celniker, Jared B., Chartier, Christopher R., Chopik, William J., Chotikavan, Poom, Chuan-Peng, Hu, Clancy, Rockwell F., Çoker, Ogeday, Correia, Rita C., Adoric, Vera Cubela, Cubillas, Carmelo P., Czoschke, Stefan, Daryani, Yalda, de Grefte, Job A. M., de Vries, Wieteke C., Burak, Elif G. Demirag, Dias, Carina, Dixson, Barnaby J. W., Du, Xinkai, Dumančić, Francesca, Dumbravă, Andrei, Dutra, Natalia B., Enachescu, Janina, Esteban-Serna, Celia, Eudave, Luis, Evans, Thomas R., Feldman, Gilad, Felisberti, Fatima M., Fiedler, Susann, Findor, Andrej, Fleischmann, Alexandra, Foroni, Francesco, Francová, Radka, Frank, Darius-Aurel, Fu, Cynthia H. Y., Gao, Shan, Ghasemi, Omid, Ghazi-Noori, Ali-Reza, Ghossainy, Maliki E., Giammusso, Isabella, Gill, Tripat, Gjoneska, Biljana, Gollwitzer, Mario, Graton, Aurélien, Grinberg, Maurice, Groyecka-Bernard, Agata, Harris, Elizabeth A., Hartanto, Andree, Hassan, Widad A. N. M., Hatami, Javad, Heimark, Katrina R., Hidding, Jasper J. J., Hristova, Evgeniya, Hruška, Matej, Hudson, Charlotte A., Huskey, Richard, Ikeda, Ayumi, Inbar, Yoel, Ingram, Gordon P. D., Isler, Ozan, Isloi, Chris, Iyer, Aishwarya, Jaeger, Bastian, Janssen, Steve M. J., Jiménez-Leal, William, Jokić, Biljana, Kačmár, Pavol, Kadreva, Veselina, Kaminski, Gwenaël, Karimi-Malekabadi, Farzan, Kasper, Arno T. A., Kendrick, Keith M., Kennedy, Bradley J., Kocalar, Halil E., Kodapanakkal, Rabia I., Kowal, Marta, Kruse, Elliott, Kučerová, Lenka, Kühberger, Anton, Kuzminska, Anna O., Lalot, Fanny, Lamm, Claus, Lammers, Joris, Lange, Elke B., Lantian, Anthony, Lau, Ivy Y.-M., Lazarevic, Ljiljana B., Leliveld, Marijke C., Lenz, Jennifer N., Levitan, Carmel A., Lewis, Savannah C., Li, Manyu, Li, Yansong, Li, Haozheng, Lima, Tiago J. S., Lins, Samuel, Liuzza, Marco Tullio, Lopes, Paula, Lu, Jackson G., Lynds, Trent, Máčel, Martin, Mackinnon, Sean P., Maganti, Madhavilatha, Magraw-Mickelson, Zoe, Magson, Leon F., Manley, Harry, Marcu, Gabriela M., Seršić, Darja Masli, Matibag, Celine-Justine, Mattiassi, Alan D. A., Mazidi, Mahdi, McFall, Joseph P., McLatchie, Neil, Mensink, Michael C., Miketta, Lena, Milfont, Taciano L., Mirisola, Alberto, Misiak, Michal, Mitkidis, Panagiotis, Moeini-Jazani, Mehrad, Monajem, Arash, Moreau, David, Musser, Erica D., Narhetali, Erita, Ochoa, Danielle P., Olsen, Jerome, Owsley, Nicholas C., Özdoğru, Asil A., Panning, Miriam, Papadatou-Pastou, Marietta, Parashar, Neha, Pärnamets, Philip, Paruzel-Czachura, Mariola, Parzuchowski, Michal, Paterlini, Julia V., Pavlacic, Jeffrey M., Peker, Mehmet, Peters, Kim, Piatnitckaia, Liudmila, Pinto, Isabel, Policarpio, Monica Renee, Pop-Jordanova, Nada, Pratama, Annas J., Primbs, Maximilian A., Pronizius, Ekaterina, Purić, Danka, Puvia, Elisa, Qamari, Vahid, Qian, Kun, Quiamzade, Alain, Ráczová, Beáta, Reinero, Diego A., Reips, Ulf-Dietrich, Reyna, Cecilia, Reynolds, Kimberly, Ribeiro, Matheus F. F., Röer, Jan P., Ross, Robert M., Roussos, Petros, Ruiz-Dodobara, Fernando, Ruiz-Fernandez, Susana, Rutjens, Bastiaan T., Rybus, Katarzyna, Samekin, Adil, Santos, Anabela C., Say, Nicolas, Schild, Christoph, Schmidt, Kathleen, Ścigała, Karolina A., Sharifian, MohammadHasan, Shi, Jiaxin, Shi, Yaoxi, Sievers, Erin, Sirota, Miroslav, Slipenkyj, Michael, Solak, Çağlar, Sorokowska, Agnieszka, Sorokowski, Piotr, Söylemez, Sinem, Steffens, Niklas K., Stephen, Ian D., Sternisko, Anni, Stevens-Wilson, Laura, Stewart, Suzanne L. K., Stieger, Stefan, Storage, Daniel, Strube, Justine, Susa, Kyle J., Szekely-Copîndean, Raluca D., Szostak, Natalia M., Takwin, Bagus, Tatachari, Srinivasan, Thomas, Andrew G., Tiede, Kevin E., Tiong, Lucas E., Tonković, Mirjana, Trémolière, Bastien, Tunstead, Lauren V., Türkan, Belgüzar N., Twardawski, Mathias, Vadillo, Miguel A., Vally, Zahir, Vaughn, Leigh Ann, Verschuere, Bruno, Vlašiček, Denis, Voracek, Martin, Vranka, Marek A., Wang, Shuzhen, West, Skye-Loren, Whyte, Stephen, Wilton, Leigh S., Wlodarczyk, Anna, Wu, Xue, Xin, Fei, Yadanar, Su, Yama, Hiroshi, Yamada, Yuki, Yilmaz, Onurcan, Yoon, Sangsuk, Young, Danielle M., Zakharov, Ilya, Zein, Rizqy A., Zettler, Ingo, Žeželj, Iris L., Zhang, Don C., Zhang, Jin, Zheng, Xiaoxiao, Hoekstra, Rink, and Aczel, Balazs

Published
2022
Full Text
View/download PDF

18. Robot-assisted Versus Open Radical Cystectomy in Bladder Cancer: An Economic Evaluation Alongside a Multicentre Comparative Effectiveness Study

Author

Helder, Sip, Venderbosch, Guus, Calsbeek, Hilly, Wijburg, Carl J., Witjes, J. Alfred, Onna, Ilze E.W.van, Barten, Evert J., Koldewijn, Evert L., Boormans, Joost L., Wijsman, Bart P., Nooter, Ronald I., Zwaan, Peter J., Slaa, Ed te, Meer, Saskia van der, Klaver, Sjoerd O., Fossion, Laurent M.C.L., Bos, Siebe D., Melick, Harm H.E.van, Leliveld, Anna M., Meijer, Richard P., Vis, André N., Molijn, Gerard J., Berendsen, Chris L., Oddens, Jorg R., Michels, Charlotte T.J., Hannink, Gerjon, Rovers, Maroeska M., and Grutters, Janneke P.C.

Published
2022
Full Text
View/download PDF

19. Study protocol for a multicenter non-inferiority randomized controlled trial to assess functional outcomes and cost-effectiveness of a primarily non-operative treatment strategy with cast immobilization versus immediate operative treatment followed by cast immobilization for patients with complete ulnar collateral ligament ruptures, including Stener lesions: MUSCAT study

Author

de Haas, Louise, van Hoorn, Bastiaan, van de Lücht, Veronique, Schep, N., Dijkgraaf, M., van Heijl, M., Debeij, J., Derksen, B., Greeven, A., Engelen, M., de Jong, J., van Laarhoven, C., Lenderink, A., Leijdesdorff, A., Leliveld, M., Leszczynksi, M., Liebrand, R., Meesters, B., Ottenhof, A., and Pesch, C.

Subjects
ULNAR collateral ligament, MEDICAL research ethics, MEDICAL ethics committees, LIGAMENT injuries, RANDOMIZED controlled trials, THUMB
Abstract

Background: Guidelines recommend operative treatment followed by cast immobilization for acute complete ulnar collateral ligament (UCL) ruptures, including Stener lesions. This recommendation is based on expert opinion, anatomic theories, and low-quality observational case series. High-quality studies comparing non-operative treatment to operative treatment are lacking. We hypothesize that primarily non-operative treatment with cast immobilization (cast immobilization) is non-inferior regarding functional outcome and carries concomitant lower costs compared with immediate operative treatment followed by cast immobilization (operative treatment) for complete UCL ruptures, including Stener lesions. Methods: This is a multicenter randomized controlled non-inferiority trial (RCT) including patients of 18 years and above, requiring treatment for an acute complete UCL rupture, including Stener lesions. Patients are randomized to cast immobilization or operative treatment followed by cast immobilization. Immobilization consists of 4 weeks of a non-removable cast around the metacarpophalangeal (MCP) and carpometacarpal (CMC) joint of the thumb in a neutral position, followed by a removable cast for 4 weeks for both groups. Patients in the cast immobilization group are re-evaluated 2 to 3 weeks after the start of cast immobilization to examine thumb stability and determine if secondary surgery is required. In case of persistent laxity, secondary surgery is required. The primary outcome is hand function expressed as the Michigan Hand outcome Questionnaire (MHQ) at 6 months (from injury to 6 months after). Discussion: If cast immobilization is non-inferior to operative treatment, the proposed treatment strategy will reduce patient burden by preventing surgery. It is expected that about one in ten patients who started with cast immobilization will need secondary surgery during re-evaluation. As a result, completion of the treatment will take longer for these patients compared to patients who received immediate operative treatment. Trial registration: Central Committee on Research Involving Human Subjects (CCMO), NL78886.100.21; registered on 4 October 2021. Medical Research Ethics Committees United (MEC-U), R21.006; registered on 09 December 2021. Clinical Trial register, identifier: NCT05291260; retrospectively registered on 22 March 2022. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Author Correction: Classification of pig calls produced from birth to slaughter according to their emotional valence and context of production

Author

Elodie F. Briefer, Ciara C.‑R. Sypherd, Pavel Linhart, Lisette M. C. Leliveld, Monica Padilla de la Torre, Eva R. Read, Carole Guérin, Véronique Deiss, Chloé Monestier, Jeppe H. Rasmussen, Marek Špinka, Sandra Düpjan, Alain Boissy, Andrew M. Janczak, Edna Hillmann, and Céline Tallet

Subjects
Medicine, Science
Published
2023
Full Text
View/download PDF

21. Classification of pig calls produced from birth to slaughter according to their emotional valence and context of production

Author

Elodie F. Briefer, Ciara C.-R. Sypherd, Pavel Linhart, Lisette M. C. Leliveld, Monica Padilla de la Torre, Eva R. Read, Carole Guérin, Véronique Deiss, Chloé Monestier, Jeppe H. Rasmussen, Marek Špinka, Sandra Düpjan, Alain Boissy, Andrew M. Janczak, Edna Hillmann, and Céline Tallet

Subjects
Medicine, Science
Abstract

Abstract Vocal expression of emotions has been observed across species and could provide a non-invasive and reliable means to assess animal emotions. We investigated if pig vocal indicators of emotions revealed in previous studies are valid across call types and contexts, and could potentially be used to develop an automated emotion monitoring tool. We performed an analysis of an extensive and unique dataset of low (LF) and high frequency (HF) calls emitted by pigs across numerous commercial contexts from birth to slaughter (7414 calls from 411 pigs). Our results revealed that the valence attributed to the contexts of production (positive versus negative) affected all investigated parameters in both LF and HF. Similarly, the context category affected all parameters. We then tested two different automated methods for call classification; a neural network revealed much higher classification accuracy compared to a permuted discriminant function analysis (pDFA), both for the valence (neural network: 91.5%; pDFA analysis weighted average across LF and HF (cross-classified): 61.7% with a chance level at 50.5%) and context (neural network: 81.5%; pDFA analysis weighted average across LF and HF (cross-classified): 19.4% with a chance level at 14.3%). These results suggest that an automated recognition system can be developed to monitor pig welfare on-farm.

Published
2022
Full Text
View/download PDF

22. EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial

Author

Anne M May, Maike G Sweegers, Wim H Van Harten, Martijn M Stuiver, Alina Vrieling, Richard P Meijer, Antoine G van der Heijden, Wim G Groen, Emine Akdemir, Helene Rundqvist, Annemarie M Leliveld-Kors, Vera C Rutten, Evert L Koldewijn, Siebe D Bos, Carl J Wijburg, Tom A T Marcelissen, Bart C Bongers, and Valesca P Retèl

Subjects
Medicine
Abstract

Introduction Radical cystectomy (RC) is the standard treatment for patients with non-metastatic muscle-invasive bladder cancer, as well as for patients with therapy refractory high-risk non-muscle invasive bladder cancer. However, 50–65% of patients undergoing RC experience perioperative complications. The risk, severity and impact of these complications is associated with a patient’s preoperative cardiorespiratory fitness, nutritional and smoking status and presence of anxiety and depression. There is emerging evidence supporting multimodal prehabilitation as a strategy to reduce the risk of complications and improve functional recovery after major cancer surgery. However, for bladder cancer the evidence is still limited. The aim of this study is to investigate the superiority of a multimodal prehabilitation programme versus standard-of-care in terms of reducing perioperative complications in patients with bladder cancer undergoing RC.Methods and analysis This multicentre, open label, prospective, randomised controlled trial, will include 154 patients with bladder cancer undergoing RC. Patients are recruited from eight hospitals in The Netherlands and will be randomly (1:1) allocated to the intervention group receiving a structured multimodal prehabilitation programme of approximately 3–6 weeks, or to the control group receiving standard-of-care. The primary outcome is the proportion of patients who develop one or more grade ≥2 complications (according to the Clavien-Dindo classification) within 90 days of surgery. Secondary outcomes include cardiorespiratory fitness, length of hospital stay, health-related quality of life, tumour tissue biomarkers of hypoxia, immune cell infiltration and cost-effectiveness. Data collection will take place at baseline, before surgery and 4 and 12 weeks after surgery.Ethics and dissemination Ethical approval for this study was granted by the Medical Ethics Committee NedMec (Amsterdam, The Netherlands) under reference number 22–595/NL78792.031.22. Results of the study will be published in international peer-reviewed journals.Trial registration number NCT05480735.

Published
2023
Full Text
View/download PDF

26. Elective nodal radiotherapy in prostate cancer

Author

De Meerleer, Gert, Berghen, Charlien, Briganti, Alberto, Vulsteke, Christof, Murray, Julia, Joniau, Steven, Leliveld, Anne M, Cozzarini, Cesare, Decaestecker, Karel, Rans, Kato, Fonteyne, Valerie, De Hertogh, Olivier, and Bossi, Alberto

Published
2021
Full Text
View/download PDF

29. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Bladder Cancer Patients: A Multicentre Comparative Effectiveness Study

Author

Wijburg, Carl J., Witjes, J. Alfred, van Onna, Ilze E.W., Barten, Evert J., Koldewijn, Evert L., Boormans, Joost L., Wijsman, Bart P., Nooter, Ronald I., Zwaan, Peter J., Slaa, Ed te, Meer, Saskia van der, Klaver, Sjoerd O., Fossion, Laurent M.C.L., Bos, Siebe D., Melick, Harm H.E.van, Leliveld, Anna M., Meijer, Richard P., Vis, André N., Molijn, Gerard J., Berendsen, Chris L., Oddens, Jorg R., Michels, Charlotte T.J., Hannink, Gerjon, Grutters, Janneke P.C., Rovers, Maroeska M., and Alfred Witjes, J.

Published
2021
Full Text
View/download PDF

31. Measurement properties of Patient-Reported Outcome Measures in patients with a tibial shaft fracture; validation study alongside the multicenter TRAVEL study

Author

Bloemers, F.W., Bruijninckx, M.M.M., De Vries, M.R., Kleinveld, S., Meijs, C.M.E.M., Mirck, B., Mollen, R.M.H.G., Ritchie, E.D., Sintenie, J.B., Termaat, M.F., Van Uden, A., Van der Vlies, C.H., Vermeulen, J., Leliveld, Mandala S., Verhofstad, Michael H.J., and Van Lieshout, Esther M.M.

Published
2021
Full Text
View/download PDF

32. Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

Author

Brück, K., Meijer, R.P., Boormans, J.L., Kiemeney, L.A.L.M., Witjes, J.A., Hoogstraten, L.M.C. van, Heijden, M.S. van der, Donders, A.R.T., Franckena, M., Uyl-de Groot, C.A., Leliveld, A.M., Aben, K.K.H., Hulshof, M.C.C., Brück, K., Meijer, R.P., Boormans, J.L., Kiemeney, L.A.L.M., Witjes, J.A., Hoogstraten, L.M.C. van, Heijden, M.S. van der, Donders, A.R.T., Franckena, M., Uyl-de Groot, C.A., Leliveld, A.M., Aben, K.K.H., and Hulshof, M.C.C.

Abstract

Item does not contain fulltext, PURPOSE: Although level I evidence is lacking that radical cystectomy (RC) is superior to bladder-preserving therapy (BPT), RC is still advocated as the recommended treatment in patients with nonmetastatic muscle-invasive bladder cancer (MIBC). This study sought to compare the survival of patients with MIBC treated with BPT versus those treated with RC. METHODS AND MATERIALS: All patients with nonmetastatic MIBC diagnoses were identified via the population-based Netherlands Cancer Registry. Only patients treated with BPT or RC were included. The primary endpoint was 2-year disease-free survival (DFS), defined as time from start of treatment until locoregional recurrence, distant metastasis, or death. The secondary endpoint was overall survival (OS). Inverse propensity treatment weighting (IPTW) was used based on propensity scores to adjust for baseline differences between treatment groups. Survival was analyzed with Kaplan-Meier and Cox proportional hazards models. RESULTS: A total of 1432 patients were included, of whom 1101 underwent RC and 331, BPT. Median follow-up was 39 months (range, 27-51 months). The IPTW-adjusted 2-year DFS was 61.5% (95% CI, 53.5%-69.6%) with BPT and 55.3% (95% CI, 51.6%-59.1%) with RC, with an adjusted hazard ratio of 0.84 (95% CI, 0.69-1.05). The adjusted 2-year OS for patients treated with BPT versus RC was 74.0% (95% CI, 67.0%-80.9%) versus 66.0% (95% CI, 62.7%-68.8%), respectively, with an adjusted hazard ratio of 0.80 (95% CI, 0.64-0.98). CONCLUSIONS: There was no statistically significant difference between the 2-year DFS of patients treated with BPT and RC. We propose that both RC and BPT should be offered as a curative treatment option to eligible patients with nonmetastatic MIBC.

Published
2024

33. Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma:Results from a Prospective Phase 2 Clinical Trial

Author

van Doeveren, Thomas, Remmers, Sebastiaan, Atema, Vera, van den Bergh, Roderick C N, Boevé, Egbert R, Cornel, Erik B, van der Heijden, Antoine G, Hendricksen, Kees, Cauberg, Evelyne C C, Jacobs, Rens A L, Kroon, Bin K, Leliveld, Annemarie M, Meijer, Richard P, Merks, Bob, Oddens, Jorg R, Roelofs, Luc, Somford, Diederik M, de Vries, Peter, Wijsman, Bart, Windt, Willemijn A K M, Zwaan, Peter J, van Leeuwen, Pim J, Boormans, Joost L, Aben, Katja K H, van Doeveren, Thomas, Remmers, Sebastiaan, Atema, Vera, van den Bergh, Roderick C N, Boevé, Egbert R, Cornel, Erik B, van der Heijden, Antoine G, Hendricksen, Kees, Cauberg, Evelyne C C, Jacobs, Rens A L, Kroon, Bin K, Leliveld, Annemarie M, Meijer, Richard P, Merks, Bob, Oddens, Jorg R, Roelofs, Luc, Somford, Diederik M, de Vries, Peter, Wijsman, Bart, Windt, Willemijn A K M, Zwaan, Peter J, van Leeuwen, Pim J, Boormans, Joost L, and Aben, Katja K H

Abstract

BACKGROUND AND OBJECTIVE: The possible negative impact of radical surgery on patients' health-related quality of life (HRQoL) plays an important role in preoperative counseling. Here, we analyzed the HRQoL of patients treated for upper urinary tract urothelial carcinoma (UTUC) in the context of a single-arm phase 2 multicenter study, in which the safety and efficacy of a single preoperative intravesical instillation with mitomycin C were investigated. Our objective was to investigate early changes in HRQoL in patients undergoing radical surgery for UTUC and identify factors associated with these outcomes.METHODS: Patients with pTanyN0-1M0 UTUC were prospectively included. HRQoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire at baseline, and at 1 and 3 mo after surgery. A linear mixed model was used to evaluate the changes in HRQoL over time and identify the variables associated with these outcomes. The clinical effect size was used to assess the clinical impact and level of perceptibility of HRQoL changes for clinicians and/or patients based on given thresholds.KEY FINDINGS AND LIMITATIONS: Between 2017 and 2020, 186 patients were included. At baseline, 1 mo after surgery, and 3 mo after surgery, response rates were 91%, 84%, and 78%, respectively. One month after surgery, a statistically significant and clinically relevant deterioration was observed in physical, role, and social functioning, and for the included symptom scales: constipation, fatigue, and pain. An improvement in emotional functioning was observed. At 3 mo, HRQoL returned to baseline levels, except emotional functioning, which improved at 1 mo and persisted to be better than that before surgery. Age >70 yr was associated with worse physical functioning, but better social and emotional functioning. Male patients reported better emotional functioning than fe

Published
2024

34. Materiaalgebruik in de urologische praktijk: kan het duurzamer?

Author

Urologie Medisch volwassenen, Zorgeenheid Urologie Medisch, Child Health, Regenerative Medicine and Stem Cells, Jansen, Sanne L., Legemate, Jaap D., Leliveld, Annemarie M., de Kort, Laetitia M.O., Urologie Medisch volwassenen, Zorgeenheid Urologie Medisch, Child Health, Regenerative Medicine and Stem Cells, Jansen, Sanne L., Legemate, Jaap D., Leliveld, Annemarie M., and de Kort, Laetitia M.O.

Published
2024

35. Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

Author

Zorgeenheid Urologie Medisch, MS Urologische Oncologie, Cancer, van Doeveren, Thomas, Remmers, Sebastiaan, Atema, Vera, van den Bergh, Roderick C.N., Boevé, Egbert R., Cornel, Erik B., van der Heijden, Antoine G., Hendricksen, Kees, Cauberg, Evelyne C.C., Jacobs, Rens A.L., Kroon, Bin K., Leliveld, Annemarie M., Meijer, Richard P., Merks, Bob, Oddens, Jorg R., Roelofs, Luc, Somford, Diederik M., de Vries, Peter, Wijsman, Bart, Windt, Willemijn A.K.M., Zwaan, Peter J., van Leeuwen, Pim J., Boormans, Joost L., Aben, Katja K.H., Zorgeenheid Urologie Medisch, MS Urologische Oncologie, Cancer, van Doeveren, Thomas, Remmers, Sebastiaan, Atema, Vera, van den Bergh, Roderick C.N., Boevé, Egbert R., Cornel, Erik B., van der Heijden, Antoine G., Hendricksen, Kees, Cauberg, Evelyne C.C., Jacobs, Rens A.L., Kroon, Bin K., Leliveld, Annemarie M., Meijer, Richard P., Merks, Bob, Oddens, Jorg R., Roelofs, Luc, Somford, Diederik M., de Vries, Peter, Wijsman, Bart, Windt, Willemijn A.K.M., Zwaan, Peter J., van Leeuwen, Pim J., Boormans, Joost L., and Aben, Katja K.H.

Published
2024

38. Are 3D Printed Models of Tibial Plateau Fractures a Useful Addition to Understanding Fractures for Junior Surgeons?

Author

Huitema, Jellina M., van der Gaast, Nynke, Brouwers, Lars, Jaarsma, Ruurd L., Doornberg, Job N., Edwards, Michael J. R., Hermans, Erik, van der Velde, Kamil, van Boxtel, Tiemen, Mannetje, Yannick ’t, Reetz, David, Rykov, Kyrill, Bolkenstein, Hendrike, Stijns, Rutger, Yauw, Simon, de Kruijf, Martijn, Strang, Steven, Fokkenrood, Hugo, Leliveld, Mandala, Horst, Matthijs ter, Wijkmans, Rian, Hoogland, Pieter, Peters, Joost, Biert, Jan, van Wageningen, Bas, Frölke, Jan Paul, van der Krol, Erik, Dierselhuis, Edwin., Holla, Micha, Hekma, Edo, Kolkman, Karel, and van de Groes, Sebastiaan

Published
2022
Full Text
View/download PDF

39. Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Author

Horstmann, Jörg, Machtens, Stefan, Mumperow, Eberhard, Ghazal, Andreas Al, Pulte, Thomas, Stephan-Odenthal, Michael, Gakis, Georgios, Kramer, Mario, Grimm, Marc-Oliver, Zaak, Dirk, Schmitz-Dräger, Bernd, Schreier, Holger, Lehmann, Jan, Werner, Torsten, Klier, Jörg, Marin, Jan, Rulf, Wolfgang, Hellmis, Eva, Schneider, Andreas, Spiegelhalder, Wirth, Manfred, Klotz, Theodor, Suttmann, Henrik, Siebels, Michael, Rodemer, Gerd, Rudolph, Robert, Zillmann, Roger, de Bruin, M., Bos, S., van Moorselaar, R., de Reijke, T, Boormans, J., Wijsman, B., van Melick, H.H.E., van Boven, E., Meijer, R.P., van der Heijden, A.G., Vergunst, H., te Slaa, E., Leliveld-Kors, A.M., Colombel, Marc, Ruffion, Alain, Pfister, Christian, Roupret, Morgan, Irani, Jacques, Stoica, Gabriel, Van Bruwaene, Siska, Ameye, Filip, Arentsen, Harm, Joniau, Steven, Beardo, Pastora, van der Heijden, Antoine G., Muilwijk, Tim, Martínez-Piñeiro, Luis, Babjuk, Marko M., Türkeri, Levent N., Palou, Joan, Patel, Anup, Bjartell, Anders S., Caris, Christien, Schipper, Raymond G., and Witjes, Wim P.J.

Published
2020
Full Text
View/download PDF

40. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

Author

Witjes, J. Alfred, Babjuk, Marek, Bellmunt, Joaquim, Bruins, H. Maxim, De Reijke, Theo M., De Santis, Maria, Gillessen, Silke, James, Nicholas, Maclennan, Steven, Palou, Juan, Powles, Tom, Ribal, Maria J., Shariat, Shahrokh F., Der Kwast, Theo Van, Xylinas, Evanguelos, Agarwal, Neeraj, Arends, Tom, Bamias, Aristotle, Birtle, Alison, Black, Peter C., Bochner, Bernard H., Bolla, Michel, Boormans, Joost L., Bossi, Alberto, Briganti, Alberto, Brummelhuis, Iris, Burger, Max, Castellano, Daniel, Cathomas, Richard, Chiti, Arturo, Choudhury, Ananya, Compérat, Eva, Crabb, Simon, Culine, Stephane, De Bari, Berardino, De Blok, Willem, J.L. De Visschere, Pieter, Decaestecker, Karel, Dimitropoulos, Konstantinos, Dominguez-Escrig, Jose L., Fanti, Stefano, Fonteyne, Valerie, Frydenberg, Mark, Futterer, Jurgen J., Gakis, Georgios, Geavlete, Bogdan, Gontero, Paolo, Grubmüller, Bernhard, Hafeez, Shaista, Hansel, Donna E., Hartmann, Arndt, Hayne, Dickon, Henry, Ann M., Hernandez, Virginia, Herr, Harry, Herrmann, Ken, Hoskin, Peter, Huguet, Jorge, Jereczek-Fossa, Barbara A., Jones, Rob, Kamat, Ashish M., Khoo, Vincent, Kiltie, Anne E., Krege, Susanne, Ladoire, Sylvain, Lara, Pedro C., Leliveld, Annemarie, Linares-Espinós, Estefania, Løgager, Vibeke, Lorch, Anja, Loriot, Yohann, Meijer, Richard, Mir, M. Carmen, Moschini, Marco, Mostafid, Hugh, Müller, Arndt-Christian, Müller, Christoph R., N'Dow, James, Necchi, Andrea, Neuzillet, Yann, Oddens, Jorg R., Oldenburg, Jan, Osanto, Susanne, J.G. Oyen, Wim, Pacheco-Figueiredo, Luís, Pappot, Helle, Patel, Manish I., Pieters, Bradley R., Plass, Karin, Remzi, Mesut, Retz, Margitta, Richenberg, Jonathan, Rink, Michael, Roghmann, Florian, Rosenberg, Jonathan E., Rouprêt, Morgan, Rouvière, Olivier, Salembier, Carl, Salminen, Antti, Sargos, Paul, Sengupta, Shomik, Sherif, Amir, Smeenk, Robert J., Smits, Anita, Stenzl, Arnulf, Thalmann, George N., Tombal, Bertrand, Turkbey, Baris, Lauridsen, Susanne Vahr, Valdagni, Riccardo, Van Der Heijden, Antoine G., Van Poppel, Hein, Vartolomei, Mihai D., Veskimäe, Erik, Vilaseca, Antoni, Rivera, Franklin A. Vives, Wiegel, Thomas, Wiklund, Peter, Williams, Andrew, Zigeuner, Richard, and Horwich, Alan

Published
2020
Full Text
View/download PDF

41. Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study

Author

Brück, Katharina, primary, Meijer, Richard P., additional, Boormans, Joost L., additional, Kiemeney, Lambertus A., additional, Witjes, J. Alfred, additional, van Hoogstraten, Lisa M.C., additional, van der Heijden, Michiel S., additional, Donders, A. Rogier, additional, Franckena, Martine, additional, Uyl de Groot, Carin A., additional, Leliveld, Annemarie M., additional, Aben, Katja K.H., additional, and Hulshof, Maarten C.C.M., additional

Published
2024
Full Text
View/download PDF

44. Publisher Correction: Situational factors shape moral judgements in the trolley dilemma in Eastern, Southern and Western countries in a culturally diverse sample

Author

Bago, Bence, Kovacs, Marton, Protzko, John, Nagy, Tamas, Kekecs, Zoltan, Palfi, Bence, Adamkovic, Matus, Adamus, Sylwia, Albalooshi, Sumaya, Albayrak-Aydemir, Nihan, Alfian, Ilham N., Alper, Sinan, Alvarez-Solas, Sara, Alves, Sara G., Amaya, Santiago, Andresen, Pia K., Anjum, Gulnaz, Ansari, Daniel, Arriaga, Patrícia, Aruta, John Jamir Benzon R., Arvanitis, Alexios, Babincak, Peter, Barzykowski, Krystian, Bashour, Bana, Baskin, Ernest, Batalha, Luisa, Batres, Carlota, Bavolar, Jozef, Bayrak, Fatih, Becker, Benjamin, Becker, Maja, Belaus, Anabel, Białek, Michał, Bilancini, Ennio, Boller, Daniel, Boncinelli, Leonardo, Boudesseul, Jordane, Brown, Benjamin T., Buchanan, Erin M., Butt, Muhammad M., Calvillo, Dustin P., Carnes, Nate C., Celniker, Jared B., Chartier, Christopher R., Chopik, William J., Chotikavan, Poom, Chuan-Peng, Hu, Clancy, Rockwell F., Çoker, Ogeday, Correia, Rita C., Adoric, Vera Cubela, Cubillas, Carmelo P., Czoschke, Stefan, Daryani, Yalda, de Grefte, Job A. M., de Vries, Wieteke C., Burak, Elif G. Demirag, Dias, Carina, Dixson, Barnaby J. W., Du, Xinkai, Dumančić, Francesca, Dumbravă, Andrei, Dutra, Natalia B., Enachescu, Janina, Esteban-Serna, Celia, Eudave, Luis, Evans, Thomas R., Feldman, Gilad, Felisberti, Fatima M., Fiedler, Susann, Findor, Andrej, Fleischmann, Alexandra, Foroni, Francesco, Francová, Radka, Frank, Darius-Aurel, Fu, Cynthia H. Y., Gao, Shan, Ghasemi, Omid, Ghazi-Noori, Ali-Reza, Ghossainy, Maliki E., Giammusso, Isabella, Gill, Tripat, Gjoneska, Biljana, Gollwitzer, Mario, Graton, Aurélien, Grinberg, Maurice, Groyecka-Bernard, Agata, Harris, Elizabeth A., Hartanto, Andree, Hassan, Widad A. N. M., Hatami, Javad, Heimark, Katrina R., Hidding, Jasper J. J., Hristova, Evgeniya, Hruška, Matej, Hudson, Charlotte A., Huskey, Richard, Ikeda, Ayumi, Inbar, Yoel, Ingram, Gordon P. D., Isler, Ozan, Isloi, Chris, Iyer, Aishwarya, Jaeger, Bastian, Janssen, Steve M. J., Jiménez-Leal, William, Jokić, Biljana, Kačmár, Pavol, Kadreva, Veselina, Kaminski, Gwenaël, Karimi-Malekabadi, Farzan, Kasper, Arno T. A., Kendrick, Keith M., Kennedy, Bradley J., Kocalar, Halil E., Kodapanakkal, Rabia I., Kowal, Marta, Kruse, Elliott, Kučerová, Lenka, Kühberger, Anton, Kuzminska, Anna O., Lalot, Fanny, Lamm, Claus, Lammers, Joris, Lange, Elke B., Lantian, Anthony, Lau, Ivy Y.-M., Lazarevic, Ljiljana B., Leliveld, Marijke C., Lenz, Jennifer N., Levitan, Carmel A., Lewis, Savannah C., Li, Manyu, Li, Yansong, Li, Haozheng, Lima, Tiago J. S., Lins, Samuel, Liuzza, Marco Tullio, Lopes, Paula, Lu, Jackson G., Lynds, Trent, Máčel, Martin, Mackinnon, Sean P., Maganti, Madhavilatha, Magraw-Mickelson, Zoe, Magson, Leon F., Manley, Harry, Marcu, Gabriela M., Seršić, Darja Masli, Matibag, Celine-Justine, Mattiassi, Alan D. A., Mazidi, Mahdi, McFall, Joseph P., McLatchie, Neil, Mensink, Michael C., Miketta, Lena, Milfont, Taciano L., Mirisola, Alberto, Misiak, Michal, Mitkidis, Panagiotis, Moeini-Jazani, Mehrad, Monajem, Arash, Moreau, David, Musser, Erica D., Narhetali, Erita, Ochoa, Danielle P., Olsen, Jerome, Owsley, Nicholas C., Özdoğru, Asil A., Panning, Miriam, Papadatou-Pastou, Marietta, Parashar, Neha, Pärnamets, Philip, Paruzel-Czachura, Mariola, Parzuchowski, Michal, Paterlini, Julia V., Pavlacic, Jeffrey M., Peker, Mehmet, Peters, Kim, Piatnitckaia, Liudmila, Pinto, Isabel, Policarpio, Monica Renee, Pop-Jordanova, Nada, Pratama, Annas J., Primbs, Maximilian A., Pronizius, Ekaterina, Purić, Danka, Puvia, Elisa, Qamari, Vahid, Qian, Kun, Quiamzade, Alain, Ráczová, Beáta, Reinero, Diego A., Reips, Ulf-Dietrich, Reyna, Cecilia, Reynolds, Kimberly, Ribeiro, Matheus F. F., Röer, Jan P., Ross, Robert M., Roussos, Petros, Ruiz-Dodobara, Fernando, Ruiz-Fernandez, Susana, Rutjens, Bastiaan T., Rybus, Katarzyna, Samekin, Adil, Santos, Anabela C., Say, Nicolas, Schild, Christoph, Schmidt, Kathleen, Ścigała, Karolina A., Sharifian, MohammadHasan, Shi, Jiaxin, Shi, Yaoxi, Sievers, Erin, Sirota, Miroslav, Slipenkyj, Michael, Solak, Çağlar, Sorokowska, Agnieszka, Sorokowski, Piotr, Söylemez, Sinem, Steffens, Niklas K., Stephen, Ian D., Sternisko, Anni, Stevens-Wilson, Laura, Stewart, Suzanne L. K., Stieger, Stefan, Storage, Daniel, Strube, Justine, Susa, Kyle J., Szekely-Copîndean, Raluca D., Szostak, Natalia M., Takwin, Bagus, Tatachari, Srinivasan, Thomas, Andrew G., Tiede, Kevin E., Tiong, Lucas E., Tonković, Mirjana, Trémolière, Bastien, Tunstead, Lauren V., Türkan, Belgüzar N., Twardawski, Mathias, Vadillo, Miguel A., Vally, Zahir, Vaughn, Leigh Ann, Verschuere, Bruno, Vlašiček, Denis, Voracek, Martin, Vranka, Marek A., Wang, Shuzhen, West, Skye-Loren, Whyte, Stephen, Wilton, Leigh S., Wlodarczyk, Anna, Wu, Xue, Xin, Fei, Yadanar, Su, Yama, Hiroshi, Yamada, Yuki, Yilmaz, Onurcan, Yoon, Sangsuk, Young, Danielle M., Zakharov, Ilya, Zein, Rizqy A., Zettler, Ingo, Žeželj, Iris L., Zhang, Don C., Zhang, Jin, Zheng, Xiaoxiao, Hoekstra, Rink, and Aczel, Balazs

Published
2022
Full Text
View/download PDF

45. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Author

Horwich, A., Babjuk, M., Bellmunt, J., Bruins, H.M., De Reijke, T.M., De Santis, M., Gillessen, S., James, N., Maclennan, S., Palou, J., Powles, T., Ribal, M.J., Shariat, S.F., Van Der Kwast, T., Xylinas, E., Agarwal, N., Arends, T., Bamias, A., Birtle, A., Black, P.C., Bochner, B.H., Bolla, M., Boormans, J.L., Bossi, A., Briganti, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Compérat, E., Crabb, S., Culine, S., De Bari, B., DeBlok, W., De Visschere, P.J.L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J.L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J.J., Gakis, G., Geavlete, B., Gontero, P., Grubmüller, B., Hafeez, S., Hansel, D.E., Hartmann, A., Hayne, D., Henry, A.M., Hernandez, V., Herr, H., Herrmann, K., Hoskin, P., Huguet, J., Jereczek-Fossa, B.A., Jones, R., Kamat, A.M., Khoo, V., Kiltie, A.E., Krege, S., Ladoire, S., Lara, P.C., Leliveld, A., Linares-Espinós, E., Løgager, V., Lorch, A., Loriot, Y., Meijer, R., Carmen Mir, M., Moschini, M., Mostafid, H., Müller, A.-C., Müller, C.R., N’Dow, J., Necchi, A., Neuzillet, Y., Oddens, J.R., Oldenburg, J., Osanto, S., Oyen, W.J.G., Pacheco-Figueiredo, L., Pappot, H., Patel, M.I., Pieters, B.R., Plass, K., Remzi, M., Retz, M., Richenberg, J., Rink, M., Roghmann, F., Rosenberg, J.E., Rouprêt, M., Rouvière, O., Salembier, C., Salminen, A., Sargos, P., Sengupta, S., Sherif, A., Smeenk, R.J., Smits, A., Stenzl, A., Thalmann, G.N., Tombal, B., Turkbey, B., Vahr Lauridsen, S., Valdagni, R., Van Der Heijden, A.G., Van Poppel, H., Vartolomei, M.D., Veskimäe, E., Vilaseca, A., Vives Rivera, F.A., Wiegel, T., Wiklund, P., Williams, A., Zigeuner, R., and Witjes, J.A.

Published
2019
Full Text
View/download PDF

49. An infrapatellar nerve block reduces knee pain in patients with chronic anterior knee pain after tibial nailing: a randomized, placebo-controlled trial in 34 patients

Author

Mandala S Leliveld, Saskia J M Kamphuis, and Michael H J Verhofstad

Subjects
Orthopedic surgery, RD701-811
Abstract

Background and purpose — Anterior knee pain is common after tibial nailing. Its origin is poorly understood. Injury of the infrapatellar nerve is a possible cause. In this randomized controlled trial we compared changes in knee pain after an infrapatellar nerve block with lidocaine or placebo in patients with persistent knee pain after tibial nailing. Patients and methods — Patients with chronic knee pain after tibial nailing were randomized to an infrapatellar nerve block with 5 ml 2% lidocaine or placebo (sodium chloride 0.9%), after which they performed 8 daily activities. Before and after these activities, pain was recorded using a numeric rating scale (NRS; 0–10). Primary endpoint was the change in pain during kneeling after the infrapatellar nerve block. Secondary outcomes were changes in pain after the nerve block during the other activities. Results — 34 patients (age 18–62 years) were equally randomized. A significant reduction of the NRS for kneeling pain with an infrapatellar nerve block with lidocaine was found compared with placebo (–4.5 [range –10 to –1] versus –1 [–9 to 2]; p = 0.002). There were no differences between the treatments for the NRS values for pain during other activities. Interpretation — Compared with placebo, an infrapatellar nerve block with lidocaine was more effective in reducing pain during kneeling in patients with chronic knee pain after tibial nailing. Our findings support the contention that kneeling pain after tibial nailing is a peripheral nerve-related problem.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results